BRÈVE publiée le 16/08/2024 à 20:43, il y a 1 année 3 mois BTTC Recognized for Ecosystem Innovation by Cointelegraph and CryptoRank Interoperability Blockchain Scalability BTTC $BTT Token
BRÈVE publiée le 16/08/2024 à 20:43, il y a 1 année 3 mois BTTC récompensé pour son innovation écosystémique par Cointelegraph et CryptoRank Blockchain Interopérabilité Évolutivité BTTC Jeton $BTT
COMMUNIQUÉ DE PRESSE publié le 16/08/2024 à 20:38, il y a 1 année 3 mois BTTC Acclaimed by Cointelegraph and CryptoRank for Ecosystem Innovation BitTorrent Chain (BTTC) receives praise from Cointelegraph and CryptoRank for its innovative ecosystem, including multi-chain protocol, asset interoperability, and strategic partnerships Blockchain BitTorrent Chain Cointelegraph CryptoRank BTTC
BRÈVE publiée le 29/02/2024 à 11:50, il y a 1 année 9 mois BitTorrent Chain : Une Force Montante dans l'Interopérabilité Blockchain selon CoinMarketCap et Reflexivity Research BitTorrent Chain Reflexivity Research Interoperabilité Blockchain CoinMarketCap Technologie Blockchain
BRÈVE publiée le 29/02/2024 à 11:50, il y a 1 année 9 mois BitTorrent Chain: A Rising Force in Blockchain Interoperability according to CoinMarketCap and Reflexivity Research Blockchain Technology BitTorrent Chain Reflexivity Research Blockchain Interoperability CoinMarketCap
COMMUNIQUÉ DE PRESSE publié le 29/02/2024 à 11:50, il y a 1 année 9 mois BitTorrent Chain Spotlighted in Reports by CoinMarketCap and Reflexivity Research BitTorrent Chain (BTTC) featured in reports by CoinMarketCap and Reflexivity Research for its innovative cross-chain interoperability solutions, infrastructure, and ecosystem BitTorrent Chain Reflexivity Research Blockchain Interoperability CoinMarketCap Cross-chain Transactions
COMMUNIQUÉ DE PRESSE publié le 29/01/2024 à 19:15, il y a 1 année 10 mois Recap of BitTorrent Chain in 2023 BitTorrent Chain has expanded its DeFi capabilities by integrating projects like Sushi, SpookySwap, and Kyberswap. It enables seamless asset transfer across Ethereum, TRON, and BNB Chain, fulfilling its mission of connecting all chains BitTorrent Chain DeFi Cross-chain Protocol EVM Compatible Asset Transfer
Publié le 04/12/2025 à 18:14, il y a 12 heures 56 minutes Résiliation d'une convention conclue entre actionnaires
Publié le 04/12/2025 à 18:00, il y a 13 heures 10 minutes Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Publié le 04/12/2025 à 18:00, il y a 13 heures 10 minutes Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Publié le 04/12/2025 à 17:45, il y a 13 heures 25 minutes Informations relatives au nombre total de droits de vote et d’actions
Publié le 04/12/2025 à 17:45, il y a 13 heures 25 minutes MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Publié le 05/12/2025 à 02:35, il y a 4 heures 35 minutes Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Publié le 05/12/2025 à 01:00, il y a 6 heures 10 minutes BEACN Closes First Tranche of Non-Brokered Private Placement
Publié le 04/12/2025 à 23:05, il y a 8 heures 5 minutes BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Publié le 04/12/2025 à 23:00, il y a 8 heures 10 minutes NXT Energy Solutions Completes Data Acquisition for SFD Survey
Publié le 05/12/2025 à 07:00, il y a 10 minutes Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Publié le 05/12/2025 à 03:30, il y a 3 heures 40 minutes CGTN: What makes cooperation between China and France a two-way success
Publié le 04/12/2025 à 23:50, il y a 7 heures 20 minutes EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Publié le 04/12/2025 à 20:25, il y a 10 heures 45 minutes Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Publié le 04/12/2025 à 20:15, il y a 10 heures 55 minutes Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
